Inside Precision Medicine January 12, 2026
Jonathan D. Grinstein, PhD

Partnerships with Dana-Farber, Brigham and Women’s, and CRI, plus a planned CLIA lab, aim to make immune and cellular profiling actionable in routine care

Serge Saxonov, PhD, sees biology one cell at a time. Since 2012, he has stood at the center of the single-cell revolution, helping drive a technological leap that fundamentally reshaped how biology is measured. Over the past decade, single-cell RNA sequencing publications have grown exponentially, propelled in large part by Saxonov’s work at 10x Genomics. By commercializing an end-to-end, user-friendly pipeline—from single-cell suspension to confident data interpretation—Saxonov and 10x Genomics eliminated steep technical barriers and democratized access to single-cell biology worldwide.

But behind it all, Saxonov has had a vision that goes beyond the pursuit of...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Conferences / Podcast, Pharma / Biotech, Trends
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
Data Visualization is Broken in Biotech: Q&A with Sunitha Venkat
Biotech investor Cormorant secures $150M for another SPAC deal

Share Article